Sprightly European stocks greet new year by hitting record high



By Marc Jones

LONDON, Jan 3 (Reuters) - World stock markets got 2022 off to a confident start on Monday after their third consecutive year of double-digit gains, while the dollar, oil prices and benchmark government bond yields all made early moves higher.

London's traders were enjoying their final day of festive rest, but mainland Europe saw a lively start, with the STOXX 600 index .STOXX notching up a quick record high after a flurry of encouraging data from the euro zone and eastern Europe.

The euro zone's Manufacturing Purchasing Managers' Index (PMI) dipped to 58.0 in December from November's 58.4, but it matched an initial "flash" estimate despite a recent surge in coronavirus infections and was still comfortably above the 50 mark separating growth from contraction.

"We're seeing some tentative but very welcome signs that the supply chain crisis which has plagued production lines all across Europe is beginning to recede," said Joe Hayes, a senior economist at IHS Markit that compiles the PMI survey.

The data also showed firms' stocks of purchases rising at a survey-record rate in December. That meant the input prices index sank to an high eight-month low, even though it remains relatively high, allowing factories to raise their prices at a much slower pace.

"Easing inflation rates are again a welcome sign, but we're still in hot territory," Hayes added.

As trading settled, bourses in Germany .GDAXI , France .FCHI , Italy .FTMIB and Spain .IBEX rose between 0.8% and 1.1%, and 10-year German government bond yields - the benchmark for European borrowing costs - were up 4 basis points at their highest level since November.

The prospect of higher rates lifted euro zone bank stocks 1.2% .SX7E while carmakers .SXAP were up 1.8% .SXAP after both Tesla and Hyundai had issued bullish targets for this year.

LIRA

In the currency markets, the euro zone data failed to lift the euro EUR= as focus remained on how much further the dollar =USD .DXY could rise if the Federal Reserve hikes U.S. interest rates a number of times this year, as is currently expected.

Turkey's lira TRY= saw a bumpy start to the year, diving as much as 5% before a partial recovery, as its central bank revealed it had used up more than $3 billion of its reserves last month when the currency slumped to record lows.

Turkey's statistics agency also reported that annual inflation jumped far more than expected to 36% year-on-year in December, the highest since September 2002.

"This reflects a vicious cycle of demand-pull inflation, which is very dangerous because the central bank had implied the price pressure was from supply constraints, and that it couldn't do anything about it," said Ozlem Derici Sengul, founding partner at Spinn Consulting in Istanbul.

The commodity markets were quickly back in the swing of things after a stellar last 18-20 months for most of them.

Oil rose towards $79 a barrel on Monday, supported by tight supply and hopes of further demand recovery in 2022 spurred in part by a view that the Omicron coronavirus variant is unlikely to shut down the global economy again.

OPEC and its allies, known as OPEC+, are expected to stick to a plan to raise output gradually at a meeting on Tuesday.

Brent crude LCOc1 , which leapt 50% last year and is up 80% from the COVID-triggered lows of 2020, rose $1 cents, or 1.3%, to $78.86 a barrel. U.S. West Texas Intermediate (WTI) crude CLc1 added $1.03 or 1.4%, to $76.24.

"Infection rates are on the rise globally, restrictions are being introduced in several countries, the air travel sector, amongst others, is suffering, yet investors' optimism is tangible," said Tamas Varga of oil broker PVM.



Global FX performance Link
Global asset performance Link
World stocks have seen $10 trillion surge in value in 2021 Link



Additional reporting by Alex Lawler in London and Oben
Mumcuoglu and Halilcan Soran in Istanbul
Editing by Gareth Jones



Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.